NEW YORK (GenomeWeb News) – Leica Biosystems today announced it has acquired Kreatech Diagnostics for an undisclosed amount.

Kreatech, based in Amsterdam, is a provider of DNA fluorescent in situ hybridization probes and target labeling reagents for microarrays. It will join Leica's Advanced Staining Business Unit based in Newcastle-upon-Tyne UK.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.